Dr. Paul Paik
Claim this profileMemorial Sloan Kettering Onc. Dept
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
12 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
NFE2L2 positive
2Non-Small Cell Lung Cancer
Stage IV
NFE2L2 positive
KEAP1 positive
Affiliated Hospitals
Clinical Trials Paul Paik is currently running
Certolizumab + Chemotherapy + Nivolumab
for Lung Cancer
The purpose of the study is to explore adding the study drug certolizumab to standard chemotherapy as it may reduce the inflammation caused by the cancer and make the chemotherapy more effective in shrinking the cancer. This study will examine whether adding certolizumab to the usual treatment approach is better than, the same as, or worse than the usual approach alone.
Recruiting1 award Phase 214 criteria
MGY825
for Lung Cancer
This trial is testing a new drug called MGY825 in adult patients with advanced lung cancer. It focuses on those with certain genetic mutations to see if the drug is safe and effective in shrinking tumors.
Recruiting1 award Phase 18 criteria
More about Paul Paik
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Paul Paik has experience with
- Pemetrexed
- Carboplatin
- MGY825
- Nivolumab
- Certolizumab
- Cisplatin
Breakdown of trials Paul Paik has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
NFE2L2 Gene Mutation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Paik specialize in?
Paul Paik focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Paul Paik currently recruiting for clinical trials?
Yes, Paul Paik is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Paul Paik has studied deeply?
Yes, Paul Paik has studied treatments such as Pemetrexed, Carboplatin, MGY825.
What is the best way to schedule an appointment with Paul Paik?
Apply for one of the trials that Paul Paik is conducting.
What is the office address of Paul Paik?
The office of Paul Paik is located at: Memorial Sloan Kettering Onc. Dept, New York, New York 10017 United States. This is the address for their practice at the Memorial Sloan Kettering Onc. Dept.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.